BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/29/2014 7:34:00 PM | Browse: 1012 | Download: 806
Publication Name World Journal of Gastroenterology
Manuscript ID 6615
Country Italy
Received
2013-10-25 14:35
Peer-Review Started
2013-10-25 19:37
To Make the First Decision
2013-12-26 11:17
Return for Revision
2013-12-26 21:12
Revised
2014-04-03 11:55
Second Decision
2014-06-26 16:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-26 17:35
Articles in Press
2014-06-26 17:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-10-17 09:28
Publish the Manuscript Online
2014-10-29 19:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title ADV36 adipogenic adenovirus in human liver disease
Manuscript Source Invited Manuscript
All Author List Francesca M Trovato, Daniela Catalano, Adriana Garozzo, G Fabio Martines, Clara Pirri and Guglielmo M Trovato
Funding Agency and Grant Number
Corresponding Author Guglielmo M Trovato, MD, Department of Medical and Pediatric Sciences, Internal Medicine, University of Catania, Policlinico, Ed. 4, 4th floor, Via Santa Sofia, 95100 Catania, Italy. guglielmotrovato@unict.it
Key Words Non-alcoholic fatty liver disease; Human adenovirus 36; obesity; Insulin resistance; Mediterranean diet; Ultrasound
Core Tip There is evidence that environmental infections, and notably adipogenic adenoviruses ADV36 /ADV37 infections in humans, are associated with obesity, being causative contributing factors of obesity in humans and animals. Lifestyle-nutritional intervention, in patients with different ADV36 seropositive status, achieves different clinical outcomes, i.e., a greater effect, on bright liver, insulin resistance and obesity is observed in comparison with ADV36 seronegative patients. These effects are not dependent on a greater pre-interventional body weight and older age. Adipogenic adenovirus infections in humans are associated with obesity, but also with allied conditions, such as fatty liver, and can have different effects on the liver in humans and animals.
Publish Date 2014-10-29 19:34
Citation Trovato FM, Catalano D, Garozzo A, Martines GF, Pirri C, Trovato GM. ADV36 adipogenic adenovirus in human liver disease. World J Gastroenterol 2014; 20(40): 14706-14716
URL http://www.wjgnet.com/1007-9327/full/v20/i40/14706.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i40.14706
Full Article (PDF) WJG-20-14706.pdf
Full Article (Word) WJG-20-14706.doc
Manuscript File 6615-Review.docx
Answering Reviewers 6615-Answering reviewers.pdf
Copyright License Agreement 6615-Copyright assignment.pdf
Peer-review Report 6615-Peer review(s).pdf
Scientific Misconduct Check 6615-CrossCheck.jpg
Scientific Editor Work List 6615-Scientific editor work list.pdf